Healthcare professionals who use Vision can now report suspected adverse reactions to MHRA directly through their clinical software.
Electronic Yellow Card reporting of suspected adverse drug reactions is being integrated into Vision, the general practice system software. This functionality is a huge step forward in accessibility of the Yellow Card Scheme to healthcare professionals.
Integration of Yellow Card reporting into clinical systems makes it easy to complete and send a Yellow Card because much of the information needed can be automatically populated from patient records. At the same time, electronic reporting provides a secure, fast, and convenient method for submitting information about suspected adverse drug reactions.
Vision is the second clinical system supplier to implement this functionality. After the 2010 introduction of electronic Yellow Card reporting into SystmOne clinical software by The Phoenix Partnership, we have seen a large increase in the number of reports from general practice. In 2016, 21% (5708) of directly reported Yellow Cards were received from the SystmOne system users.
Increased numbers of Yellow Cards makes more data available to us to identify possible drug safety issues promptly, and so helps to protect public health.
As part of the requirements under the NHS GP Systems of Choice Programme (GPSoC), all suppliers of primary care systems must integrate electronic Yellow Card facilities into their clinical software. We are establishing timelines with other suppliers as to when this reporting functionality will be added into their systems.
Article citation: Drug Safety Update volume 10 issue 7, February 2017: 2.
Published: 20 February 2017